Subunit Selective NMDA Receptor Potentiators for the Treatment of Neurological Conditions

Provided are compounds, pharmaceutical compositions and methods of treating or preventing disorders associated with NMDA receptor activity, including schizophrenia, Parkinson's disease, cognitive disorders, depression, neuropathic pain, stroke, traumatic brain injury, epilepsy, and related neurologic events or neurodegeneration. Compounds of the general Formulas A-J, and pharmaceutically acceptable salts, esters, prodrugs or derivatives thereof are disclosed.

Patents:
WO 2,010,088,414   [MORE INFO]

Inventor(s): TRAYNELIS STEPHEN F [US]; LIOTTA DENNIS C [US]; SANTANGELO ROSE M [US]; GARNIER ETHEL C [US]

Type of Offer: Licensing



« More Pharmaceutical Patents

---